Lysine Demethylase 4D gene therapy (StemCardia)

N/A

Report date: 2025/02/25 15:36:20

Base Information

Drug NameLysine Demethylase 4D gene therapy (StemCardia)
Drug Alias NameKDM4D (StemCardia)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionLysine-specific demethylase 4D gene transference
TargetsLysine-specific demethylase 4D
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStemCardia Inc
China Registration ClassN/A

Develop Information

Active CompaniesStemCardia Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A